Federal Register of Legislation - Australian Government

Primary content

PB 57 of 2014 Determinations/Health as made
This determination amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (No. PB 119 of 2008) to reflect the changes made by the National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2014 (No. 7) by the addition of two new listed drugs.
Administered by: Health
Registered 30 Jul 2014
Tabling HistoryDate
Tabled HR26-Aug-2014
Tabled Senate26-Aug-2014
Date of repeal 02 Aug 2014
Repealed by Division 1 of Part 5A of the Legislative Instruments Act 2003

PB 57 of 2014

 

National Health Determination under paragraph 98C(1)(b) Amendment 2014
(No. 7)

_____________________________________________________________________

 

 

I, PAUL CREECH, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.

 

Dated 14 July 2014

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PAUL CREECH

First Assistant Secretary (Acting)

Pharmaceutical Benefits Division

Department of Health

 

 

 

1              Name of Instrument

(1)                This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2014 (No. 7).

(2)                This Instrument may also be cited as PB 57 of 2014.

2              Commencement                                                        

                This instrument commences on 1 August 2014.

3              Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)

                Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).



Schedule 1            Amendments

 

[1]        Schedule 4, after entry for Aciclovir

insert:

Aclidinium

Powder for oral inhalation in breath actuated device containing aclidinium bromide 400 micrograms per dose, 60 doses

[2]        Schedule 4, after entry for Benzydamine

insert:

Betaine

Oral powder 180 g